200,000+ products from a single source!
sales@angenechem.com
CAS No: 188116-08-7 Catalog No: AG002GP8 MDL No:
Title | Journal |
---|---|
Modifications of antiepileptic drugs for improved tolerability and efficacy. | Perspectives in medicinal chemistry 20080101 |
The novel anxiolytic ELB139 displays selectivity to recombinant GABA(A) receptors different from diazepam. | Neuropharmacology 20070301 |
ELB139 an agonist at the benzodiazepine binding site increases 5-HT in the striatum and prefrontal cortex of rats: a microdialysis study. | Pharmacology, biochemistry, and behavior 20070101 |
Synthesis, pharmacology, and structure-activity relationships of novel imidazolones and pyrrolones as modulators of GABAA receptors. | Journal of medicinal chemistry 20060323 |
GABA-A receptors: a viable target for novel anxiolytics? | Current opinion in pharmacology 20060201 |
Targeting neurological receptors. | IDrugs : the investigational drugs journal 20051201 |
Characterization in rats of the anxiolytic potential of ELB139 [1-(4-chlorophenyl)-4-piperidin-1-yl-1,5-dihydro-imidazol-2-on], a new agonist at the benzodiazepine binding site of the GABAA receptor. | The Journal of pharmacology and experimental therapeutics 20050801 |
© 2019 Angene International Limited. All rights Reserved.